Asia Pacific Veterinary Vaccines Market
Market Introduction
APAC veterinary vaccines market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of APAC. The APAC region is expected to be the fastest-growing region among all other regions. The market is driven by the factors such as rising number of foods borne diseases among animals, growing awareness about animal health, and few hurdles for the approval of vaccines/drugs related to animal health. Moreover, increasing number of clinical trials and rising number of companies trying to enter markets in emerging economies like India, Southeast Asia and China, are expected to contribute to the market growth for veterinary vaccines market during the forecast period. Market growth in untapped economies and burgeoning awareness of diagnosis and treatment of variety of infectious diseases are the major factor driving the growth of the APAC veterinary vaccines market. However, stiff government rules related to usage of veterinary vaccines hinders the growth of APAC veterinary vaccines market.
In case of COVID-19, APAC is highly affected specially India. The impact of pandemic is far-reaching. Asian economies were among the earliest epicenters of the pandemic, but also considered to be more effective in controlling the spread of the virus. Powerful economies such as Japan, and South Korea felt the disruption that the pandemic has caused. Covid-19 have emerged as a challenge in the market of veterinary vaccines, it reduced the intensity of various veterinary activities across the globe. However, companies were focused on making animal health vaccines, drugs, and equipment more accessible to consumers by fortifying their supply chains and promoting these products as essential goods, which can be an interlude for the veterinary vaccines market overall. A revolutionized change occurred in the veterinary vaccines market due to the impact of the virus. The complete lockdown in various countries forbidden the transportation of raw materials and forbade service providers’ business. Due to which the operations of various companies failed; however, few companies managed to be afloat. For Instance: Even during the pandemic Virbac ensured the best possible continuity of commitments to veterinarians, farmers, and animal owners who, every day on the front line, continued their essential work to care for and raise those animals. Therefore, manufacturing of these vaccines became difficult to an extent, which directly impacted the APAC veterinary vaccines market.
Market Overview and Dynamics
The APAC veterinary vaccines market is expected to grow from US$ 2,257.78 million in 2021 to US$ 3,677.55 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. Animals carry hazardous bacteria, viruses, parasites, and fungi to people, resulting in illness. Such diseases are known as zoonotic diseases or zoonoses. The clinical effect of zoonotic illnesses may range from mild to severe and sometimes lead to death. Zoonotic illnesses are ubiquitous in the region. Moreover, in 2016, at least 55,000 individuals perished of rabies in the region. In the past decades, several new infectious human diseases causing viruses, such as Ebola virus, West Nile virus, Human Immunodeficiency Virus (HIV), Nipah virus, and Hantavirus infections, have evolved from animal reservoirs. Outbreaks, such as severe acute respiratory syndrome (SARS) and avian influenza, have underlined the potential of germs from animal reservoirs to adapt to human hosts. More than three-quarters of the human diseases that are new, emerging, or reemerging at the beginning of the 21st century is caused by pathogens derived from animals or products of animal origin. Over 30 novel human infections have been found in the previous three decades, and 75% of these are originated from animals. Hence, the emerging and reemerging zoonotic illnesses propel the demand for animal health. Thus, companies produce improved medications and vaccines to aid animal owners or other stakeholders to maintain the overall health of animals. Therefore, the growth in the incidence of zoonotic diseases boosts the APAC veterinary vaccines market growth.
Key Market Segments
In terms of vaccine type, the livestock vaccines segment accounted for the largest share of the APAC veterinary vaccines market in 2020. In terms of technology, the live attenuated vaccines segment held a larger market share of the APAC veterinary vaccines market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the APAC veterinary vaccines market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BIOVAC; Boehringer Ingelheim International GmbH; Ceva; Elanco; Hester Biosciences Limited; HIPRA; Merck & Co., Inc.; NEOGEN Corporation; Virbac; and Zoetis Inc. among others.
Reasons to buy report
APAC Veterinary Vaccines Market Segmentation
APAC Veterinary Vaccines Market - By Vaccine Type
APAC Veterinary Vaccines Market - By
Technology
APAC Veterinary Vaccines Market - By Country
APAC Veterinary Vaccines Market - Company Profiles
Strategic insights for the Asia Pacific Veterinary Vaccines provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2,257.78 Million |
| Market Size by 2028 | US$ 3,677.55 Million |
| Global CAGR (2021 - 2028) | 7.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Vaccine Type
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
The geographic scope of the Asia Pacific Veterinary Vaccines refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Asia Pacific Veterinary Vaccines Market is valued at US$ 2,257.78 Million in 2021, it is projected to reach US$ 3,677.55 Million by 2028.
As per our report Asia Pacific Veterinary Vaccines Market, the market size is valued at US$ 2,257.78 Million in 2021, projecting it to reach US$ 3,677.55 Million by 2028. This translates to a CAGR of approximately 7.2% during the forecast period.
The Asia Pacific Veterinary Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Veterinary Vaccines Market report:
The Asia Pacific Veterinary Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Veterinary Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Veterinary Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Veterinary Vaccines Market
